Table of Contents Table of Contents
Previous Page  1784-1785 / 2437 Next Page
Information
Show Menu
Previous Page 1784-1785 / 2437 Next Page
Page Background

0 1 2 3 4 5 6 7 8 9 10 11 12

Month

10

7

10

6

10

5

10

4

10

3

10

2

10

1

Geometric Mean Titer (95% CI)

Anti-EGFRvIII Humoral Response

Weller et al., Lancet Oncol 2017

ACT-IV outcome

Humoral immune response